Search for: All records

Foot drop is the inability to dorsiflex the ankle (raise the toes) due to neuromuscular impairment, and this common condition can cause trips and falls. Current treatments for chronic foot drop provide dorsiflexion support, but they either impede ankle push off or are not suitable for all patients. Powered ankle-foot orthosis (AFO) can counteract foot drop without these drawbacks, but they are heavy and bulky and have short battery life. To counteract foot drop without the drawbacks of current treatments or powered AFO, we designed and built an AFO powered by dielectric elastomer actuators (DEAs), a type of artificial muscle technology. This paper presents our design and the results of benchtop testing. We found that the DEA AFO can provide 49 % of the dorsiflexion support necessary to raise the foot. Further, charging the DEAs reduced the effort that would be required for plantarflexion compared to that with passive DEA behavior, and this operation could be powered for 7000 steps or more in actual operation. DEAs are a promising approach for building an AFO that counteracts foot drop without impeding plantarflexion, and they may prove useful for other powered prosthesis and orthosis designs.

Implantable neural interfaces are important tools to accelerate neuroscience research and translate clinical neurotechnologies. The promise of a bidirectional communication link between the nervous system of humans and computers is compelling, yet important materials challenges must be first addressed to improve the reliability of implantable neural interfaces. This perspective highlights recent progress and challenges related to arguably two of the most common failure modes for implantable neural interfaces: (1) compromised barrier layers and packaging leading to failure of electronic components; (2) encapsulation and rejection of the implant due to injurious tissue–biomaterials interactions, which erode the quality and bandwidth of signals across the biology–technology interface. Innovative materials and device design concepts could address these failure modes to improve device performance and broaden the translational prospects of neural interfaces. A brief overview of contemporary neural interfaces is presented and followed by recent progress in chemistry, materials, and fabrication techniques to improve in vivo reliability, including novel barrier materials and harmonizing the various incongruences of the tissue–device interface. Challenges and opportunities related to the clinical translation of neural interfaces are also discussed.

Legged and gait-assistance robots can walk more efficiently if their actuators are compliant. The adjustable compliance of variable-stiffness actuators (VSAs) can enhance this benefit. However, this functionality requires additional mechanical components making VSAs impractical for some uses due to increased weight, volume, and cost. VSAs would be more practical if they could modulate the stiffness of their springs without additional components, which usually include moving parts and an additional motor. Therefore, we designed a VSA that uses dielectric elastomer transducers (DETs) for springs. It does not need mechanical stiffness-adjusting components because DETs soften due to electrostatic forces. This paper presents details and performance of our design. Our DET VSA demonstrated independent modulation of its equilibrium position and stiffness. Our design approach could make it practical to obtain the benefits of variable-stiffness actuation with less weight, volume, and cost than normally accompanies them, once weaknesses of DET technology are addressed.